阿奇霉素联合卡介菌多糖核酸治疗糖尿病并金黄色葡萄球菌肺炎39例

Azithromycin Combination of BCG Polysaccharide Nucleic Acid Treatment of Diabetes and Staphylococcus Aureus Pneumonia in 39 Cases

目的探讨阿奇霉素联合卡介菌多糖核酸治疗糖尿病并金黄色葡萄球菌肺炎的效果。方法糖尿病并金黄色葡萄球菌患者78例为,按随机数字表法将其均分为对照组与观察组,对照组患者采用阿奇霉素联合降糖药进行治疗,观察组在此基础上加用卡介菌多糖核酸进行治疗。2周之后观察结果,所获数据采用2检验。结果观察组的治疗有效率为94.9%,对照组有效率76.9%,两组比较,P<0.05,有显著性差异;观察组有并发症者2例,对照组有并发症者1例。胸腔积水治疗观察组有效率81.8%,对照组有效率27.2%,两组比较,P<0.05,有显著性差异。结论阿奇霉素联合卡介菌多糖核酸药治疗糖尿病并金黄色葡萄球菌肺炎效果显著,值得推广。

Objective To investigate the azithromycin combination of BCG polysaccharide nucleic acid for the treatment of diabetes and staphylococcus aureus pneumonia. Methods 78 patients with diabetes and staphylococcus aureus, according to random number table method were divided into control group and observation group, the control group were treated by azithromycin combined diabetes treatment, observation group based on the use of BCG polysaccharide nucleic acid treatment. 2 weeks after the observation, data obtained by X-2 test. Results The treatment group effective rate was 94.9%, the control effectiveness 76.9%, compared two groups, P〈0.05, there is significant difference;Observation group with complications in 2 cases, control group with complications in 1 case. Pleural effusion treatment group effective rate was 81.8%, the control effectiveness 27.2%, compared two groups, P〈0.05, there is significant difference. Conclusion Azithromycin combination of BCG polysaccharide nucleic acid drug treatment of diabetes and staphylococcus aureus pneumonia effect is remarkable, and is worth promoting.